Company News, Financial News

Oddity Invests $100 Million to Bring Pharma’s AI-Based Molecule Discovery Technology to Beauty and Wellness

Acquisition of Revela will boost the expansion of proprietary, science-backed and clinically tested products to benefit consumers globally.

Author Image

By: Lianna Albrizio

Associate Editor

Oddity, the consumer technology platform built to transform the global beauty and wellness market, has acquired Boston-based Revela, an industry leading biotechnology startup and forerunner in artificial intelligence-based molecule discovery for beauty and wellness indications, for $76 million.    With the acquisition, the company will establish Oddity Labs in Boston with an additional $25 million investment for its frontier lab. The business combination will boost the development and ex...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters